Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$799 Hold
7
– – ﹤0.01% 1182
2026
Q2
$747 Hold
7
– – ﹤0.01% 1161
2026
Q1
$1.14K Sell
7
-2
-22% -$307 ﹤0.01% 1017
2025
Q4
$1.57K Buy
9
+2
+29% +$365 ﹤0.01% 1037
2025
Q3
$1.01K Hold
7
– – ﹤0.01% 1064
2025
Q2
$705 Buy
7
+1
+17% +$76 ﹤0.01% 1352
2025
Q1
$458 Buy
+6
New +$459 ﹤0.01% 1545

Other funds holding INSM

SouthState's INSM Position: Q3 2026 in Review

SouthState held its Insmed (INSM) position steady in Q3 2026 at 7 shares worth $799. The position accounts for ﹤0.01% of the portfolio, ranked #1182.

SouthState first reported a position in INSM in Q1 2025 and has held it in 7 quarters since. The position peaked at $1.57K in Q4 2025. 547 funds tracked by Wall St. Rank hold INSM as of Q3 2026.

  • SouthState held 7 shares of Insmed worth $799 as of Q3 2026.
  • SouthState left its Insmed share count unchanged in Q3 2026.
  • Insmed made up ﹤0.01% of SouthState's portfolio in Q3 2026, its #1182 holding.
  • SouthState first reported a position in Insmed in Q1 2025 and has held it in 7 quarters since.
  • SouthState's Insmed position peaked at $1.57K in Q4 2025.
  • 547 funds tracked by Wall St. Rank held Insmed as of Q3 2026.

Based on SouthState's 13F filing for Q3 2026, filed 9 Nov 2026.